Insiders · Profile

Marshall Ken W.

Commercial Leader at Aquestive Therapeutics. Filing since 21 Nov 2018. CIK 0001740092

Company

Date

Role

Action

Shares

Amount

Of holding

AQST Aquestive Therapeutics, Inc.

21 Nov 2018

Commercial Leader

Bought

1,445

$14.67K

opened

1 decision on file.